公司资料
Creative Medical Technology Holdings 股价、新闻与催化剂
- 股票代码:
- CELZ
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.10 USD (-9.84%)
收盘价
最后更新: 2026年8月17日
8.24M USD
市值
股价为何变动
As of Aug 17, 2026, CELZ closed down 9.84% at $1.10. No new same-company headline was identified in the current news window.
公司概览
业务概览
Creative Medical Technology Holdings is a regenerative medicine company focused on cell-based and biologic approaches to difficult diseases. Its story is built around early-stage platform science and the possibility of translating regenerative concepts into practical therapies.
所在地与行业分类
Creative Medical Technology is headquartered in the United States and listed on NASDAQ. It sits in regenerative medicine and small-cap biotech rather than commercial pharma.
商业模式特征
The company depends on preclinical and early clinical validation, platform credibility, and capital support. Investors typically watch scientific updates, financing, and whether the company can narrow its story into a viable development path.
生物医药行业定位
Creative Medical Technology occupies a speculative regenerative-medicine niche within biotech. It tends to trade on platform promise more than on near-term commercial visibility.
未来催化剂
- Creative Medical’s catalysts are regenerative-medicine and immunotherapy programs, plus any update that shows the company can still create a path forward. The stock remains very much proof-of-concept driven.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。